Low-density lipoproteins (LDLs) are the so-called "bad" lipoproteins. Which statement best reflects why high levels of LDL are considered unhealthy?
There is an increased risk of hyperthyroidism.
There is an increased risk of heart disease.
There is the possibility of digestive problems.
There is an increased risk of rhabdomyolysis.
The Correct Answer is B
A) There is an increased risk of hyperthyroidism:
High levels of LDL cholesterol are not associated with hyperthyroidism. Hyperthyroidism is a condition related to an overactive thyroid gland, which affects metabolism and hormone levels but does not directly impact LDL cholesterol levels.
B) There is an increased risk of heart disease:
LDL cholesterol, often referred to as "bad cholesterol," contributes to the buildup of fatty plaques in the walls of arteries, a process known as atherosclerosis. This buildup can narrow and harden the arteries, leading to reduced blood flow and increasing the risk of heart disease, including conditions such as coronary artery disease, heart attack, and stroke. High LDL levels are considered one of the most significant modifiable risk factors for cardiovascular disease.
C) There is the possibility of digestive problems:
While very high cholesterol levels can sometimes contribute to the formation of gallstones, high LDL cholesterol levels are not directly linked to digestive problems. The primary concern with high LDL is its contribution to cardiovascular disease rather than digestive health.
D) There is an increased risk of rhabdomyolysis:
Rhabdomyolysis is a condition caused by the breakdown of muscle tissue, which can lead to the release of muscle proteins into the bloodstream. While certain medications used to lower cholesterol, such as statins, can cause muscle pain and, in rare cases, lead to rhabdomyolysis, high LDL itself is not a direct cause of rhabdomyolysis. The main health concern with high LDL is its contribution to heart disease.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A) Patients with hypertension
Low molecular weight heparin (LMWH) is not primarily used to treat hypertension. Hypertension (high blood pressure) is typically managed with antihypertensive medications like ACE inhibitors, beta-blockers, diuretics, or calcium channel blockers. LMWH is an anticoagulant, which works to prevent blood clots rather than controlling blood pressure.
B) Patients with asthma
LMWH is not typically used to treat asthma. Asthma is a chronic respiratory condition that is usually managed with bronchodilators (e.g., albuterol) and anti-inflammatory drugs such as corticosteroids. While patients with asthma may be at risk for blood clots under certain conditions (e.g., severe asthma exacerbations, immobility), LMWH is not a first-line treatment for asthma.
C) Patients with diabetes
While people with diabetes may be at an increased risk of developing blood clots, LMWH is not specifically used to treat diabetes. Diabetes is typically managed with insulin, oral hypoglycemic agents, lifestyle modifications, and other medications to control blood glucose levels. LMWH is an anticoagulant used for conditions that require prevention of clot formation, such as deep vein thrombosis (DVT).
D) Patients with deep vein thrombosis (DVT)
LMWH is commonly prescribed to patients with deep vein thrombosis (DVT). DVT occurs when a blood clot forms in a deep vein, usually in the legs. LMWH is a type of anticoagulant that prevents the formation of further clots by inhibiting factors involved in blood clotting. It is especially effective for patients with DVT or those at high risk for thromboembolic events, such as after surgery or during prolonged immobility. LMWH provides more predictable anticoagulation and requires less frequent monitoring than unfractionated heparin, making it ideal for outpatient management and in hospital settings.
Correct Answer is B
Explanation
A) Esophagus
Enteric-coated tablets are designed to not dissolve or disintegrate in the esophagus. They are coated with a protective layer that prevents the tablet from breaking down in the acidic environment of the stomach. This is to ensure that the medication is released in the part of the digestive tract where it is most needed, typically beyond the stomach.
B) Duodenum
Enteric-coated tablets are designed to disintegrate in the duodenum, which is the first part of the small intestine. The coating protects the tablet from stomach acid, allowing it to pass intact through the stomach and into the small intestine, where the pH is higher and the coating dissolves, releasing the medication for absorption.
C) Stomach
Enteric-coated tablets are specifically designed not to disintegrate in the stomach because the stomach's acidic environment could either damage the drug or cause premature release. The coating ensures that the drug is protected until it reaches the more neutral pH of the duodenum.
D) Colon
The colon is too far along in the digestive tract for enteric-coated tablets to typically disintegrate. The design of enteric coatings is intended to protect the drug until it reaches the duodenum, where absorption is most efficient. Enteric coatings are not meant to disintegrate in the colon.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.